253 related articles for article (PubMed ID: 1606293)
1. Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrand's disease. UK Regional Haemophilia Centre Directors Committee.
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):205-14. PubMed ID: 1606293
[No Abstract] [Full Text] [Related]
2. Prevalence of antibody to HIV in haemophiliacs in the United Kingdom: a second survey. AIDS Group of the United Kingdom Haemophilia Centre Directors with the co-operation of the United Kingdom Haemophilia Centre Directors.
Clin Lab Haematol; 1988; 10(2):187-91. PubMed ID: 3262033
[TBL] [Abstract][Full Text] [Related]
3. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
Fukui H
Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):866-74. PubMed ID: 1919201
[No Abstract] [Full Text] [Related]
4. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
[TBL] [Abstract][Full Text] [Related]
5. Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease.
Miners AH; Sabin CA; Tolley KH; Lee CA
J Intern Med; 1998 Dec; 244(6):515-22. PubMed ID: 9893105
[TBL] [Abstract][Full Text] [Related]
6. Protocols for the treatment of haemophilia and von Willebrand disease.
Kasper CK;
Haemophilia; 2000 Jul; 6 Suppl 1():84-93. PubMed ID: 10982273
[No Abstract] [Full Text] [Related]
7. Management of common congenital disorders of haemostasis.
Ekert H
Paediatrician; 1980; 9(2):81-8. PubMed ID: 6771736
[TBL] [Abstract][Full Text] [Related]
8. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom.
Rizza CR; Spooner RJ
Br Med J (Clin Res Ed); 1983 Mar; 286(6369):929-33. PubMed ID: 6403138
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against Australia-antigen in haemophilia.
Nordenfelt E; Nilsson IM
Rev Eur Etud Clin Biol; 1971 Feb; 16(2):151-5. PubMed ID: 5313698
[No Abstract] [Full Text] [Related]
10. Acquired immunodeficiency syndrome and other possible immunological disorders in European haemophiliacs.
Bloom AL
Lancet; 1984 Jun; 1(8392):1452-5. PubMed ID: 6145888
[TBL] [Abstract][Full Text] [Related]
11. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
Gamba G; Grignani G; Nicolini E; Ascari E
Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
[No Abstract] [Full Text] [Related]
12. Frequency and clinical and transfusional significance of rheumatoid factor in patients with haemophilia and von Willebrand's disease.
Celada A; Aguado MT; Ortega F; Magallon M; Martin-Villar J; Lambert PH
Vox Sang; 1984; 47(4):271-5. PubMed ID: 6333107
[TBL] [Abstract][Full Text] [Related]
13. West Virginia State Hemophilia Program.
Jubelirer SJ; Ohgren LC; Haddy L; Stevenson M; Rogers JS
W V Med J; 1985 Dec; 81(12):259-61. PubMed ID: 3878628
[No Abstract] [Full Text] [Related]
14. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
Janković GM; Janosević S
Haematologia (Budap); 1978-1979; 12(1-4):183-8. PubMed ID: 317061
[TBL] [Abstract][Full Text] [Related]
15. Scuba diving is possible and safe for patients with haemophilia.
Schved JF; De Haro M; Drapeau M; Schved M
Haemophilia; 2012 Jan; 18(1):75-9. PubMed ID: 21535321
[TBL] [Abstract][Full Text] [Related]
16. Occurrence rates of inherited bleeding disorders other than haemophilia and von Willebrand disease among people receiving care in specialized treatment centres in the United States.
Miller CH; Soucie JM; Byams VR; Payne AB; Abe K; Lewandowska M; Shapiro AD
Haemophilia; 2022 May; 28(3):e75-e78. PubMed ID: 35245405
[No Abstract] [Full Text] [Related]
17. Recent advances in the detection of carriers of haemophilia A, B and Von Willebrand's disease.
Schinco PM; Rizza CR
Haematologica; 1983; 68(1):124-34. PubMed ID: 6404703
[No Abstract] [Full Text] [Related]
18. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
Janković GM
Thromb Res; 1979; 16(3-4):557-64. PubMed ID: 316208
[No Abstract] [Full Text] [Related]
19. Circulating immune complexes in haemophilia and von Willebrand's disease.
Passaleva A; Massai G; Morfini M; Longo G; Rossi Ferrini PL; Ricci M
Scand J Haematol; 1983 Nov; 31(5):466-74. PubMed ID: 6606214
[TBL] [Abstract][Full Text] [Related]
20. Treatment of haemophilia A and v. Willebrand's disease.
Nilsson IM
Bibl Haematol; 1965; 23():1307-12. PubMed ID: 5296087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
